Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 1, 2009, Pages 40-45

  Vermeulen, Beatrijs A N ^a   Hogen Esch, Caroline E ^a   Yüksel, Zehre ^a   Koning, Frits ^a   Verduijn, Willem ^a   Doxiadis, Ilias I N ^a   Schreuder, Geziena M Th ^a   Mearin, M Luisa ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coeliac disease; Genetics

Indexed keywords

HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ7 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CELIAC DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK ASSESSMENT;

CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; MALE; MASS SCREENING; PHENOTYPE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 58149087528     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802116422     Document Type: Article

References (33)

1. Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 2005;19:373-87.
2. Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992;35:188-92.
3. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-50.
4. Vader LW, De Ru A, van der WY, Kooy YM, Benckhuijsen W, Mearin ML, et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002;195:643-9.
5. Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002;97:695-9.
6. Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, et al. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 2003;61:308-16.
7. Monsuur AJ, Wijmenga C. Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann Med 2006;38:578-91.
8. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341-4.
9. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827-9.
10. Green PH, Jabri B. Coeliac disease. Lancet 2003;362:383-91.
11. George EK, Mearin ML, Franken HC, Houwen RH, Hirasing RA, Vandenbroucke JP. Twenty years of childhood coeliac disease in The Netherlands: a rapidly increasing incidence? Gut 1997;40:61-6.
12. Steens RF, Csizmadia CG, George EK, Ninaber MK, Hira Sing RA, Mearin ML. A national prospective study on childhood celiac disease in the Netherlands 1993-2000: an increasing recognition and a changing clinical picture. J Pediatr 2005;147:239-43.
13. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet 1999;353:813-4.
14. Mearin ML. Celiac disease among children and adolescents. Curr Probl Pediatr Adolesc Health Care 2007;37:86-105.
15. Mearin ML, Koninckx CR, Biemond I, Polanco I, Pena AS. Influence of genetic factors on the serum levels of antigliadin antibodies in celiac disease. J Pediatr Gastroenterol Nutr 1984;3:373-7.
16. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993;41:173-7.
17. Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 1994;40:138-42.
18. Zubillaga P, Vidales MC, Zubillaga I, Ormaechea V, Garcia-Urkia N, Vitoria JC. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr 2002;34:548-54.
19. Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R, et al. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol 2006;41:191-9.
20. Mustalahti K, Holopainen P, Karell K, Maki M, Partanen J. Genetic dissection between silent and clinically diagnosed symptomatic forms of coeliac disease in multiplex families. Dig Liver Dis 2002;34:842-5.
21. Mearin ML, Biemond I, Pena AS, Polanco I, Vazquez C, Schreuder GT, et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983;24:532-7.
22. Mearin ML, Bouquet J, Mourad N, Schoorel E, Sinaasappel M, Biemond I, et al. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet 1985;27:45-50.
23. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003;100:12390-5.
24. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK, et al. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-11.
25. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992;102:330-54.
26. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
27. Verduyn W, Doxiadis II, Anholts J, Drabbels JJ, Naipal A, D'Amaro J, et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993;37:59-67.
28. Schouten HJA. Klinische statistiek, een praktische inleiding in methodologie en analyse. Bohn Satfleu Van loghum Houten/Diegem 1999.
29. Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, et al. The HLA dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Int J Immunogenet 2005;32:19-69.
30. Jores RD, Frau F, Cucca F, Grazia CM, Orru S, Rais M, et al. HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease. Scand J Gastroenterol 2007;42:48-53.
31. Al Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006;4:315-9.
32. Greco L, Percopo S, Clot F, Bouguerra F, Babron MC, Eliaou JF, et al. Lack of correlation between genotype and phenotype in celiac disease. J Pediatr Gastroenterol Nutr 1998;26:286-90.
33. Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol 2007;5:1399-405.